RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- June L Almenoff, MD, PhD
RedHill Biopharma, Inc.
Study Chair - Kevin L. Winthrop, MD, MPH
Oregon Health and Science University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical Facility
Glendale, California, United States
- Medical Facility
Palm Springs, California, United States
- Medical Facility
Farmington, Connecticut, United States
- Medical Facility
Washington D.C., District of Columbia, United States
- Medical Facility
Clearwater, Florida, United States
- Medical Facility
Gainesville, Florida, United States
- Medical Facility
Margate, Florida, United States
- Medical Facility 1
Orlando, Florida, United States
- Medical Facility 2
Orlando, Florida, United States
- Medical Facility
Sebring, Florida, United States
- Medical Facility
Vero Beach, Florida, United States
- Medical Facility
Atlanta, Georgia, United States
- Medical Facility
Valdosta, Georgia, United States
- Medical Facility
Kansas City, Kansas, United States
- Medical Facility
New Orleans, Louisiana, United States
- Medical Facility
Boston, Massachusetts, United States
- Medical Facility
Rochester, Minnesota, United States
- Medical Facility
St Louis, Missouri, United States
- Medical Facility
Newark, New Jersey, United States
- Medical Facility
New York, New York, United States
- Medical Facility
Winston-Salem, North Carolina, United States
- Medical Facility
Portland, Oregon, United States
- Medical Facility
Charleston, South Carolina, United States
- Medical Facility
Tyler, Texas, United States
- Medical Facility
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Dec 2020
- Primary completion
- 28 Aug 2023
- Completion
- 28 Aug 2023
- Last update posted
- 18 Mar 2025
- Registered enrollment
- 12
- Registry id
- NCT04616924
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.